DARIOHEALTH CORP (DRIO)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
$2.73-8.25%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
QuarterlyIQ Insights · DRIO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -76.4% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 25.7% |
Growth built into the price is above our model estimate.
The price assumes 102.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 1 industry peers
DRIO — President transition
Dated 2026-08-21
President and Chief Commercial Officer — Steven Nelson: The President and Chief Commercial Officer is leaving the company following an extended medical leave, representing the loss of a senior executive without an immediate named successor.
Why it matters: The operating loss narrowed to $6.5 million in Q2 2026. Further cuts would show progress in managing costs.
Supportive ifQ3 operating loss is less than $6.5 million.
Worry ifQ3 operating loss is $6.5 million or more.
Why it matters: Dario raised about $23.5 million for working capital, investments, and acquisitions. The report can show how the funds were used.
Watch forThe November 12 report names a use for the funds and shows cash from the offering on the balance sheet.
Also watch forThe report says the offering did not close, or shows no cash from the offering.
Why it matters: Revenue fell to $5.2 million in Q2 2026. A rise would show that commercial growth is gaining ground.
Supportive ifQ3 revenue is above $5.2 million, the Q2 2026 level.
Worry ifQ3 revenue is $5.2 million or lower.
Why it matters: Gross profit fell to $3.2 million in Q2 2026. A rise would mark progress on a long-running company goal.
Supportive ifQ3 gross profit is above $3.2 million.
Worry ifQ3 gross profit is $3.2 million or lower.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$308 on $10,000 · ±3.1% | How much price usually moves either way. |
| Bad day | $959 loss on $10,000 · 9.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,879 loss on $10,000 · 78.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.